OVERVIEW

Improving Clinical and Cost Outcomes in Hyperkalemia is organized by Healthcare Made Practical (HMP) Communications LLC and will be held from Dec 20, 2018 - Dec 20, 2019.

Accreditation:
CME
NACCME designates this enduring activity for a maximum of 1 AMA PRA Category 1 Credit™.
Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Physician Assistants
NACCME has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with the AAPA CME Criteria. This activity is designated for 1 AAPA Category 1 credit(s).

CNE
This continuing nursing education activity awards 1 contact hour.
Provider approved by the California Board of Registered Nursing, Provider #13255 for 1 contact hour.

CPE
This activity is approved for 1.0 contact hour (.1 CEU) of continuing pharmacy education (UAN:JA0006201-0000-18-241-H01-P).

Intended Learners:
This activity is designed for pharmacy directors, medical directors, and other decision makers working in managed care organizations.

Learning Objectives:
After completing this activity, participants should be able to:
• Quantify the clinical and economic burden of hyperkalemia and the impact of suboptimal management on outcomes
• Support protocols to enhance the identification of patients with/at risk for hyperkalemia
• Evaluate recent potassium binders in terms of safety, efficacy, labeling, dosing and role in acute, sub-acute, and chronic hyperkalemia management strategies
• Integrate the latest clinical and pharmacoeconomic data into evidence-based formulary decisions and benefits design